The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2015

Filed:

May. 20, 2011
Applicants:

Tongalp H. Tezel, Louisville, KY (US);

Henry J. Kaplan, Louisville, KY (US);

Robert A. Mitchell, Louisville, KY (US);

John O. Trent, Louisville, KY (US);

Inventors:

Tongalp H. Tezel, Louisville, KY (US);

Henry J. Kaplan, Louisville, KY (US);

Robert A. Mitchell, Louisville, KY (US);

John O. Trent, Louisville, KY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/517 (2006.01); A61K 39/395 (2006.01); A61K 31/505 (2006.01); A61K 31/53 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 31/505 (2013.01); A61K 31/53 (2013.01); A61K 45/06 (2013.01);
Abstract

Methods for modulating eye damage associated with a disease or disorder, and/or damage incident to trauma including but not limited to trauma associated with ocular surgery are provided. In some embodiments, the methods include administering an effective amount of a modulator of a migration inhibitory factor (MIF) polypeptide biological activity to a subject. Also provided are methods for modulating the severity of delaying the onset of and/or inhibiting and/or preventing the development of an ocular disease, and methods for modulating the severity of delaying the onset of and/or inhibiting and/or preventing the development of scarring and/or other consequence of wound healing incident to ocular surgery, as well as modulating the survival, function, and/or differentiation of engrafted cells that can be employed as part of tissue engineering procedures to correct structural, functional, and/or cellular defects of the eye.


Find Patent Forward Citations

Loading…